Lawrenceville, NJ, United States of America

Mary F Malley

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 7.3

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Lawrenceville, NJ (US) (2008 - 2013)
  • Princeton, NJ (US) (2012 - 2014)

Company Filing History:


Years Active: 2008-2014

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: Mary F Malley: Innovator in Pharmaceutical Chemistry

Introduction

Mary F Malley is a prominent inventor based in Lawrenceville, NJ (US). She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 9 patents. Her work primarily focuses on the development of novel pharmaceutical compounds and processes.

Latest Patents

Among her latest patents is the invention related to crystal forms of saxagliptin and processes for preparing the same. This patent provides physical crystal structures of a compound, including various forms and pharmaceutical compositions that can be used in treating diseases such as diabetes. Another notable patent involves a process for preparing atazanavir bisulfate, an HIV protease inhibitor. This process details the reaction of atazanavir free base with concentrated sulfuric acid to produce highly crystalline forms of the bisulfate salt.

Career Highlights

Mary F Malley has worked with leading pharmaceutical companies, including Bristol-Myers Squibb Company and AstraZeneca AB. Her expertise in pharmaceutical development has led to advancements in drug formulations and therapeutic applications.

Collaborations

Throughout her career, she has collaborated with notable professionals in the field, including Jack Z Gougoutas and Chenkou Wei. These collaborations have contributed to her innovative research and patent developments.

Conclusion

Mary F Malley is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug development. Her contributions continue to impact the field positively, showcasing her dedication to innovation and research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…